Sponsor Check › Person
Related person on Form D filings · address states as listed: CA, NY, MA · listed Sep 30, 2009 → Oct 25, 2018
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
10 of 20 offerings report sales commissions totalling $15,132,539; 1 reports finder's fees totalling $31,502; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Mar 29, 2024 D File 021-509031 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 5, 2024 D File 021-501744 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 23, 2020 D File 021-369538 | $4,000,000 (est.) | $0 | $0 | GP Nurmenkari Inc. BrokerCheck CRD 153480 ↗ T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Jan 27, 2020 D File 021-358981 | $1,200,000 (est.) | $0 | $0 | GP Nurmenkari Inc. BrokerCheck CRD 153480 ↗ T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Jan 13, 2020 D File 021-357840 | $563,200 (est.) | $0 | $0 | GP Nurmenkari Inc. BrokerCheck CRD 153480 ↗ T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Oct 25, 2018 D File 021-324378 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 25, 2018 D File 021-324379 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 25, 2018 D File 021-324382 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 25, 2018 D File 021-324385 | $14,500 | $0 | $0 | T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Oct 25, 2018 D File 021-324387 | $313,180 | $0 | $0 | T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Oct 25, 2018 D File 021-324388 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 6, 2018 D File 021-320736 | $200,000 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 17, 2018 D File 021-317099 | $363,222 | $0 | $0 | T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Jul 17, 2018 D File 021-317100 | $3,000,000 | $0 | $0 | GP Nurmenkari Inc. BrokerCheck CRD 153480 ↗ H.C. Wainright & Co., LLC BrokerCheck CRD 375 ↗ T.R. Winston & Company, LLC BrokerCheck CRD 10571 ↗ |
| EDGAR ↗ | Apr 5, 2017 D File 021-284161 | $0 | $31,502 (est.) | $0 | Arcadia Securities, LLC no CRD number reported via Arcadia Securities, LLC (CRD 50764 ↗) |
| EDGAR ↗ | Jun 15, 2016 D File 021-265134 | $4,000,000 | $0 | $0 | Jefferies LLC BrokerCheck CRD 2347 ↗ Piper Jaffray & Co. BrokerCheck CRD 665 ↗ |
| EDGAR ↗ | Nov 15, 2013 D File 021-206402 | $1,478,437 | $0 | $0 (est.) Certain proceeds may be used for general working capital purposes which may include compensation and other payments to executive officers listed in Item 3. | Roth Capital Partners, LLC BrokerCheck CRD 15407 ↗ Scarsdale Equities LLC BrokerCheck CRD 134602 ↗ American Portfolio Financial Services, Inc. BrokerCheck CRD 18487 ↗ Agincourt, Ltd. BrokerCheck CRD 36661 ↗ |
| EDGAR ↗ | Sep 30, 2009 D/A File 021-120805 | $0 | $0 | $0 The Investment Manager will receive a management fee and an affiliate may receive an incentive allocation, each paid by an affiliate of the Issuer, in an amount equal to a percentage of the value of each shareholders shares. | None listed on this filing |
| EDGAR ↗ | Sep 30, 2009 D/A File 021-120813 | $0 | $0 | $0 The Investment Manager will receive a management fee, and the General Partner may receive a performance allocation, each paid by an affiliate of the Issuer, in an amount equal to a percentage of each limited partner's capital account. | None listed on this filing |
| EDGAR ↗ | Sep 30, 2009 D/A File 021-123235 | $0 | $0 | $0 The Investment Manager will receive a management fee in an amount equal to a percentage of each limited partner's capital account. The General Partner will receive a performance allocation equal to a percentage of each limited partner's capital account | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Elicio Therapeutics, Inc. group: Elicio Therapeutics | Director | Mar 29, 2024 | D | $6,000,000 similar: $2,000,000–$19,999,994 | $6,000,000 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Elicio Therapeutics, Inc. group: Elicio Therapeutics | Director | Jan 5, 2024 | D | $7,047,530 similar: $2,000,000–$19,999,994 | $7,047,530 | 1 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Elicio Therapeutics, Inc. group: Elicio Therapeutics | Executive Officer, Director Chief Executive Officer | Jun 23, 2020 | D | $40,000,000 similar: $2,000,000–$19,999,994 | $6,695,000 | 54 similar: 2–16 | $25,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Elicio Therapeutics, Inc. group: Elicio Therapeutics | Executive Officer, Director Chief Executive Officer | Jan 27, 2020 | D | $12,000,000 similar: $2,000,000–$19,999,994 | $1,000,000 | 7 similar: 2–16 | $65,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Elicio Therapeutics, Inc. group: Elicio Therapeutics | Executive Officer, Director Chief Executive Officer | Jan 13, 2020 | D | $12,000,000 similar: $2,000,000–$19,999,994 | $6,081,980 | 51 similar: 2–16 | $10,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Tivorsan Pharmaceuticals, Inc. | Director | Oct 25, 2018 | D | $1,000,000 similar: $1,694,259–$16,000,000 | $900,000 | 4 similar: 1–13 | $25,000 similar: $10,000–$55,000 |
| EDGAR ↗ | Tivorsan Pharmaceuticals, Inc. | Director | Oct 25, 2018 | D | $4,474,000 similar: $1,694,259–$16,000,000 | $4,474,000 | 32 similar: 1–13 | $10,000 similar: $10,000–$55,000 |
| EDGAR ↗ | Tivorsan Pharmaceuticals, Inc. | Director | Oct 25, 2018 | D | $2,938,000 similar: $1,694,259–$16,000,000 | $2,938,000 | 35 similar: 1–13 | $5,000 similar: $10,000–$55,000 |
| EDGAR ↗ | Tivorsan Pharmaceuticals, Inc. | Director | Oct 25, 2018 | D | $1,636,250 similar: $1,694,259–$16,000,000 | $1,636,250 | 8 similar: 1–13 | $80,000 similar: $10,000–$55,000 |
| EDGAR ↗ | Tivorsan Pharmaceuticals, Inc. | Director | Oct 25, 2018 | D | $2,767,751 similar: $1,694,259–$16,000,000 | $2,767,751 | 14 similar: 1–13 | $25,000 similar: $10,000–$55,000 |
| EDGAR ↗ | Tivorsan Pharmaceuticals, Inc. | Director | Oct 25, 2018 | D | $1,124,824 similar: $1,694,259–$16,000,000 | $1,124,824 | 2 similar: 1–13 | $250,000 similar: $10,000–$55,000 |
| EDGAR ↗ | Transplant Genomics Inc. | Director | Sep 6, 2018 | D | $7,977,713 similar: $829,831–$9,999,998 | $7,977,713 | 31 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Elicio Therapeutics, Inc. group: Elicio Therapeutics | Executive Officer, Director Chief Executive Officer | Jul 17, 2018 | D | $35,000,000 similar: $2,000,000–$19,999,994 | $15,379,000 | 133 similar: 2–16 | $15,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Elicio Therapeutics, Inc. group: Elicio Therapeutics | Executive Officer, Director Chief Executive Officer | Jul 17, 2018 | D | $5,438,891 similar: $2,000,000–$19,999,994 | $5,438,891 | 18 similar: 2–16 | $50,063 similar: $10,000–$50,000 |
| EDGAR ↗ | Transplant Genomics Inc. | Director | Apr 5, 2017 | D | $5,525,247 similar: $500,000–$7,000,000 | $3,169,532 | 27 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Lion Biotechnologies, Inc. | Director | Jun 15, 2016 | D | $100,000,000 similar: $2,000,000–$19,999,994 | $100,000,000 | 24 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Lion Biotechnologies, Inc. | Director | Nov 15, 2013 | D | $23,290,600 similar: $2,000,000–$19,999,994 | $23,290,600 | 117 similar: 2–16 | $10,000 similar: $10,000–$50,000 |
| EDGAR ↗ | AYER CAPITAL PARTNERS KESTREL FUND LP group: Ayer | Promoter Founder and principal of the Issuer's General Partner and Investment Manager | Sep 30, 2009 | D/A | Indefinite similar: $155,000–$5,250,000 | $2,200,000 | 7 similar: 4–27 | $1,000,000 similar: $1,000–$100,000 |
| EDGAR ↗ | AYER CAPITAL PARTNERS FUND LP group: Ayer | Promoter Founder and principal of the Issuer's General Partner and Investment Manager | Sep 30, 2009 | D/A | Indefinite similar: $155,000–$5,250,000 | $33,200,000 | 11 similar: 4–27 | $3,000,000 similar: $1,000–$100,000 |
| EDGAR ↗ | AYER CAPITAL PARTNERS FUND LTD group: Ayer | Director, Promoter Founder and principal of the Issuer's Investment Manager | Sep 30, 2009 | D/A | Indefinite similar: $155,000–$5,250,000 | $10,000,000 | 1 similar: 4–27 | $3,000,000 similar: $1,000–$100,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Jay Venkatesan. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Jay Venkatesan appears on a new Form D, or when a court case or SEC action is matched to them. See plans →